Gastroenterology Education and CPD for trainees and specialists » ASCO GI: Agent Shows Promise in Pancreatic Cancer

- Gastroenterology Education and CPD for trainees and specialists - https://www.gastrotraining.com -

ASCO GI: Agent Shows Promise in Pancreatic Cancer

SAN FRANCISCO (MedPage Today) — A liposomal formulation of irinotecan (CPT-11) passed an early clinical test in metastatic pancreatic cancer, meeting survival and safety endpoints for continued evaluation.

Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com